Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD

Clinical trial NCT07148297 · RECRUITING

Trial details

NCT number: NCT07148297
Sponsor: Epiliquid Holding, Inc
Status: RECRUITING
Study type: OBSERVATIONAL

Colo-rectal Cancer

Start date: 2021-06-30
Primary completion: 2025-08-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.